Printer Friendly
The Free Library
19,111,409 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADM Tronics Receives Two Patents for Medical Device for Treatment of Neuro-Cerebral Disorders.


NORTHVALE, N.J.--(BUSINESS WIRE)--Nov. 10, 1999--

ADM Tronics Unlimited, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:ADMT ADMT Active Directory Migration Tool
ADMT Air Dry Metric Ton
ADMT Automated Data Management Tool
) announced that the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property  has issued two patents for the Company's non-invasive medical device for treating neuro-cerebral disorders such as multiple sclerosis and Parkinson's disease. The technology covered by these patents, called "NCCD" for Neuro-Cerebral Corona Discharge, was invented by Dr. Alfonso Di Mino, President and founder of ADM Tronics and Andre' Di Mino, Executive Vice President. They have assigned the patents to ADM Tronics.

The first patent, "Corona Discharge Beam Treatment of Neuro-Cerebral Disorders" covers the basic technology for a medical device to non-invasively treat a patient's neuro-cerebral condition with a pulsatory pul·sa·to·ry  
adj.
Having rhythmical vibration or movement.
 corona discharge of a complex electronic energy signal. The second patent, "Computer-Controlled Servo-Mechanism for Positioning Corona Discharge Beam Applicator ap·pli·ca·tor
n.
An instrument for applying something, such as a medication.


applicator,
n a device for applying medication; usually a slender rod of glass or wood, used with a pledget of cotton on the end.
" covers the technology for a system to accurately position the device to efficiently treat a patient's brain and spinal column with the output.

Initial limited clinical testing with the NCCD has been promising. However, ADM Tronics' management cautions that it believes widespread availability of this therapy is at least several years off. "Now that we have protected the technology with patents, we can begin to explore wider clinical testing for presentation to the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
," stated Andre' Di Mino. "We are also looking for strategic relationships that would help to move this technology through the clinical and regulatory process."

ADM Tronics is a technology based developer and manufacturer of a diversified line of products categorized into three distinct market segments - therapeutic, non-invasive electronic medical devices, environmentally safe chemical products and innovative topical dermatological products.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 11, 1999
Words:264
Previous Article:Agilent Technologies and Organon Teknika Announce Product Development and Distribution Agreement for Muscle Relaxation Monitoring Equipment.
Next Article:Prime Response Ranks in Inc. 500 as One of The Year's Fastest Growing Privately Held Companies In U.S.
Topics:



Related Articles
ADM Tronics Begins Distribution of Medical Device for Tinnitus Sufferers.
ADM Tronics Secures Third Patent On Medical Device for Treatment of Neuro-Cerebral Disorders.
MEDAREX/NEURO THERAPEUTICS TO DEVELOP ANTIBODY THERAPEUTICS.
Secondary Prevention of Cerebral Ischemia in Patent Foramen Ovale: Systematic Review and Meta-analysis.
MEDICURE GETS U.S. PATENT NOTICE OF ALLOWANCE FOR THERAPEUDICS.
SOMAXON EXERCISES OPTION TO LICENSE NALMEFENE.
All-purpose defoamer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles